Whether patients with hepatitis B minor triple positive need antiviral treatment at present depends on the state of the patient. If one’s liver function has never shown any abnormality and the morphology of the liver is completely normal, antiviral treatment is not recommended for the time being. Because the current antiviral drugs have not been able to achieve the degree of complete elimination of the hepatitis B virus, can only control the replication of the hepatitis B virus, the cyclic double-stranded DNA will still exist within the liver cells, can not be eliminated by the drugs, can not cure hepatitis B, can only control the amount of the virus, so as to control the virus on the liver cells caused by further damage. When there is no damage to liver function, there is no point in taking antiviral drugs. It only makes sense to take antiviral drugs when there has been recurrent damage, or progression to cirrhosis. Patients with hepatitis B teratitis minor should only take antiviral drugs when they are in a carrier state if drugs capable of removing the hepatitis B virus from the liver appear later.